We have evaluated gene transfer efficiency to tumor nodules in diethylnitrosoamine (DENA)-induced hepatocellular carcinoma (HCC) in rats using adenoviral vectors administered by three different routes: intraportal, intra-arterial and intratumoral injection. Our results showed that intraportal infusion could not transduce tumor nodules greater than 1 mm in diameter while the intra-arterial route allowed transduction of nodules up to 2-5 mm in diameter. Tumors greater than this size were resistant to transduction by intravascular route, but could be transduced by direct intratumoral injection, indicating that the obstacle preventing gene transfer to tumor cells was mainly at the level of tumor vasculature and not at the level of neoplastic cells. We have studied the extracellular matrix in tumoral lesions to assess whether nodules with different size and histological pattern have different profiles in relation to transduction efficacy. Immunohistochemical detection showed a high expression of fibronectin (FN), laminin (LN) and ␣-smooth muscle actin (␣-
Introduction
Hepatocellular carcinoma (HCC) is one of the most common tumors and causes the death of 1 300 000 people worldwide every year. 1, 2 Morbidity and mortality in HCC are primarily the result of aggressive local spread rather than the occurrence of distant metastasis. No effective therapy can be offered to patients with unresectable HCC since conventional chemotherapy or radiotherapy is ineffective in this form of malignancy. [3] [4] [5] Thus new therapies are urgently needed.
Gene therapy has emerged as a new promising approach to treat tumors. Different gene therapy strategies such as virus-mediated transfer of suicide genes, [6] [7] [8] cytokine genes [9] [10] [11] and tumor suppressor genes 12 have been applied to treat HCC. However, most of these studies have used animal models based on transplantation of established tumor cell lines to immunocompetent SMA) in those large HCC, which were resistant to adenoviral infection. Intra-arterial infusion of vasoactive compounds (histamine, angiotensin II or nitric oxide donor nitroglycerin) before vector administration enhanced gene transfer to tumor nodules that were poorly transduced without pre-treatment. Nitroglycerin was active to enhance transduction of large tumors with trabecular or pseudoglandular histological pattern, which were impermeable to adenoviral vectors even after histamine or angiotensin treatments. Our data indicate the presence of a physical barrier between blood and neoplastic cells, which prevents transduction of the tumor by vectors given by the intravascular route. The thickness and impermeability of the barrier increases as the tumor nodule grows. Vasoactive compounds may be of value in gene therapy of liver cancer by increasing transduction efficiency by intravascularly administered vectors. Gene Therapy (2000) 7, 1824-1832.
animals or immunodeficient nude mice, 6, [8] [9] [10] [11] a situation which does not reflect the real scenario of HCC in humans. A model closer to the human situation is the induction of HCC with carcinogens such as diethylnitrosoamine (DENA) which causes the development of HCC through different steps with formation of preneoplastic foci, neoplastic nodules and eventually HCC nodules of different size. [13] [14] [15] In previous reports we and others have shown that in this animal model, gene transfer to large tumor nodules was very low by intraportal administration of adenoviral vectors. 7, 16, 17 Since primary liver tumors receive blood supply mainly from the hepatic artery, 18 some authors have compared the intraportal and intra-arterial route for vector administration in DENAinduced HCC. 17 These investigators found better gene transfer efficiency by intra-arterial injection than by intraportal administration of adenovirus but large tumors were not transduced even by the intra-arterial route. 17 In a previous work we have proposed that there is a physical barrier between blood and tumor cells that would be responsible for poor transduction of tumor nodules with vectors used in gene therapy. 7 Capillarization of sinusoids, formation of basement membrane and activation of hepatic stellate cells (HSC) have been described to occur in HCC. 19 HSC are the main producers of extracellular matrix components including basement membrane proteins, and therefore play an important role in capillarization of sinusoids in the liver. 20 Since these changes may prevent the transport of particles and macromolecules from the vascular lumen to neoplastic cells, in the present work we have used the rat model of DENA-induced HCC to investigate whether there was a correlation between the transducibility of tumoral nodules of different size by an adenoviral vector given intravascularly and the activation of HSC and formation of basement membrane in these lesions. In addition, we have evaluated whether the use of vasoactive compounds might allow a better transduction of impermeable nodules. Our results show that as tumor nodules increase in size, there is an increased expression of alpha-smooth muscle actin (␣-SMA, a marker of HSC activation 19 ) and a higher deposition of laminin (LN) and fibronectin (FN) (two basement membrane proteins 21, 22 ) in parallel with an increased difficulty for transduction by adenoviral vectors. Histamine, angiotensin II and specially nitroglycerin have been found to be effective in increasing gene transfer to large HCC nodules.
Results
Transduction of HCC cells by intraportal and intraarterial administration of adenovirus expressing lacZ (AdCMVlacZ) Three tumor-bearing animals in each group received 2 × 10 10 p.f.u. of AdCMVlacZ by the intraportal or intraarterial route and gene transfer efficiency was evaluated in neoplastic nodules and HCCs of different size. Intraportal administration of AdCMVlacZ resulted in transduction of 50-60% of nontumoral liver cells. As shown in Figure 1a and b, and Table 1 , gene transfer to neoplastic nodules smaller than 1 mm in diameter was very efficient with a transduction rate similar to that of nontumoral parenchyma. However, only very few X-gal-positive cells were seen in neoplastic nodules bigger than 1 mm in diameter (Figure 1c and d and Table 1 ). HCC nodules were also very poorly transducible by this route. Differences in transduction were found in relation to the histology of HCC nodules: while a few X-gal-positive cells were observed in HCC tumors of the compact histological type (Figure 1e ), pseudoglandular ( Figure 1f ) and trabecular HCC nodules (Figure 1g and h) were absolutely nontransducible.
Intra-arterial administration of the vector resulted in transduction of 30-40% of nontumoral liver cells. By this route neoplastic nodules with diameter up to 2 mm could be effectively transduced and gene transfer efficiency was similar or even better than that of surrounding nontumoral liver cells (Figure 2a and b, and Table 1 ). Transduction of 7% of tumor cells was found in HCC nodules with diameter ranging from 2 to 5 mm while HCCs larger than 5 mm were very poorly transduced ( Table 1 ). The diverse histological types of HCC showed different resistance to gene transfer. Thus, tumors of compact type bigger than 2 mm showed some degree of transduction (Figure 2c and d), although less than those smaller than 2 mm, but tumors with pseudoglandular (Figure 2e and f) and trabecular (Figure 2g and h) histological patterns were more 
Gene transfer to HCC cells by intratumoral administration of AdCMVlacZ
In order to investigate whether resistance to transduction of big HCC nodules was due to difficulties for the vector to be expressed in HCC cells or to factors preventing the access of the vector to neoplastic cells when administered intravascularly, we performed direct intratumoral injection of 2 × 10 10 p.f.u. of AdCMVlacZ into HCC nodules bigger than 5 mm in diameter. As shown in Figure 3 , when the vector was injected directly into HCC nodules, HCC cells could be efficiently transduced at the site of the injection along the path of the injecting needle. In addition, about 2% of nontumoral tissue was also transduced when the adenovirus was injected intratumorally. The transduction of nontumoral tissue is probably due to Gene transfer efficiency in tumors from rats which received AdCMVlacZ (2 × 10 10 p.f.u. per rat) alone either by intra-portal vein (IP) injection or by intra-hepatic artery (HA) injection or which were treated with vasoactive agents through the hepatic artery before receiving the vector by the same route. Hist, histamine; AII, angiotensin II; DSM, degradable starch microspheres; NG, nitroglycerine; NN, neoplastic nodules; HCC, hepatocellular carcinoma nodules; NA, not available. *P Ͻ 0.05 and **P Ͻ 0.01 either compared between IP and HA routes or between pre-treatment with vasoactive compounds and without pre-treatment.
passage of the vector to systemic circulation, gaining access by this route to the rest of the liver parenchyma. These findings indicate that low transduction of big HCC nodules when the adenovirus is given intravascularly is not due to intrinsic resistance of tumor cells to incorporate and express the vector, but rather to unique characteristics of tumor microenvironment.
Immunohistochemistry
In order to see whether changes in tumor vasculature might contribute to poor gene transfer efficiency of tumors by vectors administered intravascularly, we studied ␣-SMA immunoreactivity and the deposition of basal membrane components (FN and LN) in tumor lesions at different stages of tumor progression in the DENA model of HCC. Immunohistochemical expression of ␣-SMA, FN and LN is shown in Figure 4 and semiquantitative assessment is given in Table 2 . In nontumoral liver, ␣-SMApositive cells were found at the portal tracts corresponding to smooth muscle cells of small arteries and veins and around bile ducts (Figure 4 , arrows) and also they were found in the wall of hepatic veins, but none or only very few positive cells were detectable in the hepatic lobule. In small tumor nodules (less than 2 mm) ␣-SMA reactive cells were present as a thin discontinuous layer along the sinusoid (Figure 4b ). However an intense expression of ␣-SMA densely distributed within the tumor nodule was observed in HCC lesions of greater size (Figure 4c ).
In the normal liver parenchyma, FN was found surrounding bile ducts and blood vessels and also as a delicate thin layer along the sinusoidal walls (arrowheads) (Figure 4d ). Small neoplastic nodules (less than 2 mm) showed a slight although noticeable increase in the expression of FN as thin discontinuous strands surrounding groups of cells (Figure 4e ). In HCC nodules of greater size, FN deposition was markedly increased with thick interconnecting strands within the tumoral lesion ( Figure 4f ).
In nontumoral liver, LN was mainly found around the blood vessels and bile duct walls but no staining was seen along the walls of the sinusoids (Figure 4g ). Small neoplastic nodules exhibited a very thin discontinuous layer of LN along the sinusoidal walls ( Figure 4h , empty arrows). In HCC lesions of bigger size the deposition of LN increased substantially with a prominent and continuous layer of this protein being observed along the cords of neoplastic cells in big HCC lesions of trabecular histological type (Figure 4i , empty arrows).
These results show an increase deposition of basement membrane proteins and ␣-SMA expression as the tumoral lesions grow. This process parallels the progressive difficulty in transduction of the tumor nodules with adenoviral vectors as the tumoral lesions increase in size suggesting that changes in tumoral interstitium and microvasculature may cause refractoriness of the tumor for transduction with gene therapy vectors.
Vasoactive compounds increase gene transfer to tumor nodules Since histamine [23] [24] [25] enhances endothelial permeability by opening pores along the intercellular junctions of endothelial cells and angiotensin II 26 can increase blood flow to HCC nodules by selective vasoconstriction of arterioles in normal liver tissue, we tried to increase gene transfer efficiency to HCC lesions by intra-arterial infusion of these vasoactive agents 1 min before intra-arterial administration of the vector (2 × 10 10 p.f.u.). Two different doses of histamine (0.4 and 2 mg) and of angiotensin II (40 and 200 ng) were used.
Gene transfer to nontumoral tissue was slightly enhanced by histamine (40-60%) and slightly reduced by angiotensin II (20-30%) as compared with untreated cases (30-40%). Compared with transduction rates in rats without previous treatment, pretreatment with histamine both at high and low doses did not change gene transfer efficiency in small tumors (Ͻ2 mm). It should be remembered that these lesions were well transduced without pretreatment (Table 1) . However histamine was able to enhance moderately transduction efficiency in tumors greater than 2 mm in diameter ( Figure 5a and Table 1 ). Nevertheless, enhancement of cell transduction was only observed in tumors with compact histological pattern, but not in trabecular and pseudoglandular tumors. Similar findings were obtained with angiotensin II (Table 1) . Pretreatment with this compound resulted in increased gene transfer efficiency in HCC nodules of compact histological pattern greater than 2 mm (Figure 5b and Table  1 ) but very little effect was observed on trabecular and pseudoglandular forms of HCC.
To increase gene transfer efficiency to large tumors further, we combined degradable starch microspheres (DSM) with angiotensin II. 27, 28 Preconditioning of the tumoral liver with this combined treatment resulted in increased transduction of nontumoral tissue (40-60% transduction rate) and of small tumor nodules (Table 1 ). In addition transduction efficiency above 20% was observed in tumor nodules between 2-5 mm and greater than this size (Figure 5c and d and Table 1 ). This enhancement in gene transfer to large tumor nodules was only obtained in lesions with compact histology, but not in the other two morphological varieties. In order to achieve efficient transduction of trabecular and pseudoglandular HCC nodules we tested nitroglycerin, a nitric oxide donor, because of the reported effects of nitric oxide on blood flow and vascular permeability in tumor microcirculation. 29 Pretreatment of the tumoral liver with two different doses of nitroglycerin (40 and 100 g) did Gene Therapy not alter transduction rate in nontumoral parenchyma (30-40%) and slightly increased gene transfer to small neoplastic nodules (Table 1 ). This treatment augmented transduction efficiency in HCC nodules of 2-5 mm and greater than 5 mm (Figure 5e and f and Table 1 ). More importantly, nitroglycerin was able to increase gene transfer to HCC nodules of trabecular and pseudoglandular pattern (as can be seen in Figure 5g and h) which showed marked resistance to transduction even with the help of all the previous treatments tested. In this respect it is useful to compare Figure 2f and h with Figure  5g and h.
All animals were killed 2 days after treatment and liver samples were collected for H&E staining to evaluate pathological changes in liver due to possible toxic effects of the vasoactive treatments applied. No obvious hepatic toxicity was observed in liver samples from the different experimental groups of animals studied.
Discussion
The efficacy of cancer gene therapy critically depends on the ability of the vector that contains the transgene to gain access to neoplastic cells and to transduce the tumor mass effectively. Animal models based on implantation of subcutaneous tumor nodules treated by intratumoral injection of the vector do not mimic the clinical situation of multifocal liver lesions that are difficult to treat by direct intratumoral puncture. In this work we have used the rat model of DENA-induced HCC to assess the efficacy of intravascular access to multifocal hepatocellular carcinoma.
As previously reported by us and others, 7, 16, 17 transduction efficiency of tumor nodules was very low when using the portal vein as the route for administering the vector. In this work we found that tumor nodules greater
Figure 4 Immunohistochemical localization of ␣-SMA positive cells, fibronectin and laminin in nontumoral liver (a, d, g), in small neoplastic nodules (less than 2 mm in diameter) (b, e, h) and in large HCC nodules (more than 5 mm in diameter) (c, f, i). Immunostaining for ␣-SMA (arrows) in the normal liver shows positivity in vessel walls and surrounding the bile ducts of the portal tracts (a). Small neoplastic nodules show ␣-SMA positive cells along the sinusoidal wall in a discontinuous manner (b). In large HCC nodules, the expression of ␣-SMA is considerably enhanced and an increased number of ␣-SMA positive cells surround groups of tumoral cells (c). In nontumoral liver immunoreactivity for FN (arrowheads) is found in the perisinusoidal space and in the vessels wall (d). In small neoplastic nodules FN is seen as strands around group of cells (e). Thicker strands of FN are found in big HCC nodules (f). In nontumoral liver immunoreactive LN (empty arrows) is observed around the hepatic vein (g). Immunoreactivity for LN is observed in the sinusoids of the small neoplastic nodules as a thin discontinuous layer (h). In large HCC nodules a continuous layer of intense immunoreactivity can be observed (an HCC of the trabecular histological type is shown in the figure) (i). (a-i × 200).
than 1 mm in diameter were not transduced by intraportal infusion of adenovirus and that intra-arterial injection of the vector resulted in a higher rate of gene transfer to tumors between 1 and 2 mm, but tumors greater than this size were very poorly transduced, especially those of trabecular and pseudoglandular type. These specific histopathological types of tumor nodules were almost com- pletely refractory to transduction. The slightly higher efficiency of the intra-arterial as compared with intraportal route possibly reflects the fact that irrigation of intrahepatic tumor nodules mainly depends on arterial supply rather than on the portal blood. 18 In a seminal paper, Shaffner and Popper 30 described the capillarization of hepatic sinusoids in liver cirrhosis as a process that could interfere with exchange between blood and hepatocytes. In a similar way, electron microscopy studies revealed the existence of ultrastructural changes in tumor microvasculature, which include the presence of a continuous non-fenestrated endothelium and the deposition of extracellular matrix between endothelium and the neoplastic cells. [31] [32] [33] [34] Immunohistochemical studies [35] [36] [37] [38] [39] have shown that this extracellular matrix consists mainly of LN, FN and collagen type IV. In the present work we have observed that as tumor nodules become larger there is a higher expression of ␣-SMA and a more prominent deposition of LN and FN. We also show that these changes occur in parallel with an increasing difficulty to transduce the neoplastic lesions with adenoviral vectors. These data suggest that activation of HSC in tumor nodules might contribute to sinusoidal capillarization and to increased production of extracellular matrix components leading to the formation of a physical barrier between the vascular lumen and the tumoral cells limiting the access of adenovirus to the neoplastic tissue.
The development of HCC is characterized by a multistage process of tumor progression. As mentioned, from our data it seems that the tumor nodule, as it grows, experiences a process of maturation involving the formation of a barrier that makes the tumor impermeable to adenoviral vectors and that may also favor tumor growth by isolating tumor cells from systemic homeostatic mechanisms including immune cells and antibodies. It is possible that this barrier also limits the efficacy of chemotherapeutic agents thus playing a role in tumor resistance to other forms of treatment in addition to gene therapy. [40] [41] [42] [43] Besides the formation of a vascular barrier, other factors in the intratumoral microenvironment can protect tumor cells against antineoplastic agents. In this respect it has been shown 41, 42 that the diffusion of molecules through solid tumors is hampered by the abnormal high pressure in the interstitial matrix, particularly in tumors surrounded by a fibrous capsule. 43 The theory that the changes that occur in tumor microvasculature are the main obstacle for transduction of neoplastic cells, is supported by the observation that it is possible to achieve high transduction efficiency in large tumor nodules by direct injection of the vector. Of importance, intratumoral injection results not only in transduction of the injected nodule, but also of the nontumoral liver parenchyma and of small tumor nodules that have not yet formed a physical blood-tumor barrier. It is possible then to gain access to distant small micrometastasis within the liver by performing direct injection of a single tumor nodule.
As shown in Figure 5a -f and Table 1 , histamine, angiotensin II with or without DSM and the nitric oxide donor nitroglycerin were found to enhance transduction of large tumor nodules. Histamine augments the permeability of endothelium by opening intercellular junctions [23] [24] [25] and creating endothelial pores, and has been used to open the blood-brain barrier in experimental models of glioma. 24, 44 Angiotensin II produces temporary vasoconstriction in normal liver arterioles, but not in tumor vasculature that is immature and unable to vasoconstrict because of diminished angiotensin II receptors and lack of both nerve supply and smooth muscle in the vessel wall. 26 As a result, angiotensin II may augment blood flow to HCC nodules, thus increasing transduction efficiency with adenoviral vectors. Interestingly, the effect of angiotensin II was increased by DSM. These microspheres consist of starch polymers with a mean diameter of 45 m which are degraded in vivo by serum ␣-amylase in about 30 min. 27, 28 Administration of DSM via hepatic artery transiently reduces hepatic arterial flow because of intrahepatic sinusoidal blockage. It has been shown that the tumor/normal liver distribution ratio of a marker may be doubled when AII is co-administered with DSM. 45 Nitric oxide is a pluripotent regulatory molecule which is involved in the regulation of microvasculature. 29 Physiological levels of nitric oxide maintain the vascular integrity, but high levels induce vasodilatation and microvascular leakage. Our data show that enhancement of gene transfer by histamine and angiotensin II + DSM occurred only in tumors with compact histology but not in tumors with a trabecular and pseudoglandular histological pattern. However, the nitric oxide donor nitroglycerin was able to increase gene transfer efficiency not only in large HCC tumors showing a compact histological pattern, but also in those with pseudoglandular and trabecular histology. This was of interest since these varieties of HCC were almost totally impermeable to adenoviral vectors and showed resistance to other vasoactive compounds. However, the potential usefulness of nitroglycerin to make tumoral tissue more permeable to gene therapy vectors should be compounded by the possible anti-apoptotic effects of this substance for neoplastic cells 46 and the possibility that its vasoactive properties might favor metastasis. 47 In addition, the dose of nitroglycerin which has been administered in the present study is about 10 to 20 times greater (on a body weight basis) than the dose of intravenous nitroglycerin employed in patients with heart disorders. 48 This might be an additional limitation to the use of nitric oxide donors to enhance vascular permeability in solid tumors.
To conclude, our data indicate that as the tumor grows tumor vasculature becomes impermeable to gene therapy Gene Therapy vectors. In order to obtain an efficient transduction of the malignancy the vector should be administered by direct intratumoral injection. However, the tumoral liver may be conditioned by treatments with vasoactive substances to enhance the transduction of neoplastic cells when gene therapy vectors are given intra-arterially.
Materials and methods

Construction of recombinant adenoviruses
The construction of the recombinant replication-defective adenovirus expressing lacZ (AdCMVlacZ) has been described previously. 49 Recombinant adenovirus was isolated from a single plaque, expanded in the 293 cells, and purified by double cesium chloride ultracentrifugation. The purified virus was extensively dialyzed against 10 mm Tris/1 mm MgCl 2 , and stored in aliquots at −80°C. The virus titer was determined by plaque assay.
Induction of HCC in rats
Primary liver tumors were induced in Wistar rats (6 weeks old, 170 g) with diethylnitrosoamine (DENA) (Sigma, St Louis, MO, USA) as described previously. 7 Briefly, animals received 10 mg/kg/day of DENA for 15 weeks. The weight of the rats was recorded every week. Rats were given weekly doses of DENA in a volume corresponding to the estimated water consumption of 6 days of drinking water (0.01% v/v). Once the animals ingested the DENA solution, they were given DENA-free water for the rest of the week. DENA solution was prepared each week. Tumor formation was monitored by killing one rat a week during the period of DENA administration. At the end of the induction period, rats presented multiple tumor nodules in the liver ranging from microscopic neoplastic nodules to HCC nodules with diameter up to 12 mm. All animals received care in compliance with the Guide for the Care and Use of Laboratory Animals at the Animal Facility of the University of Navarra.
Administration of adenovirus with or without previous treatment with vasoactive compounds
Twenty-five tumor-bearing rats were divided into 11 groups: AdCMVlacZ was given through the portal vein (PV) in three rats, through the hepatic artery (HA) in three other rats and by direct intratumoral injection (IT) in two other animals (groups 1, 2 and 3 respectively). The rest of the groups were treated intra-arterially with different vasoactive compounds 1 min before intra-arterial administration of the adenoviral vector. Group 4 (n = 2) and 5 (n = 2) received intra-arterially 200 l of solution containing 0.4 mg and 2 mg of histamine (Sigma); group 6 (n = 2) and 7 (n = 2) received intra-arterially 40 ng and 200 ng of AII (Sigma) respectively; group 8 (n = 2) and 9 (n = 2) received intra-arterially 25 ng of AII + 2 mg of degradable starch microspheres (DSM) (Pharmacia, Uppsala, Sweden) and 75 ng of AII + 2 mg of DSM, respectively; group 10 (n = 2) and 11 (n = 3) received intra-arterially 40 and 100 g of nitroglycerin (NG) (Solinitrina; Berenguer-Infale, Barcelona, Spain). A dose of 2 × 10 10 plaque forming unit (p.f.u.) AdCMVlacZ per animal in 1 ml of 0.9% NaCl solution was used for all groups. For intratumor injection we used the same dose of adenovirus diluted in 0.2 ml.
Rats were anesthetized with ketamine-atropinediazepan. Intratumoral injection was performed with a 27-gauge needle. Intraportal infusion was done using a 26-gauge catheter for about 2 min and after vector administration, gel foam was applied to the site of injection. For the hepatic artery infusion, a butterfly with a 27-gauge needle was inserted into the gastroduodenal artery using an operating microscope (×16 magnification). After administration of AdCMVlacZ ± vasoactive compound, the gastroduodenal artery was ligated and the presence of appropriate hepatic blood flow was confirmed. In total, 31 animals were treated. Five rats died during the surgical procedure and one animal from group 9 died 40 h after treatment. The remaining 25 rats were successfully treated and included in this study.
Gene transfer, histology and immunohistochemistry Two days after vector administration, animals were killed. To study gene expression, nine liver specimens per rat were obtained from different regions including tumor and nontumor areas. Specimens were fixed in formalin or placed in OCT (Tissue-Tek, Zoeterwonde, The Netherlands). The latter were snap-frozen in isopentane precooled with liquid nitrogen. Two serial sections of 6 m thickness were made from each frozen specimen and fixed in 0.5% glutaraldehyde buffered in PBS pH 7.0 for 10 min at 4°C. After fixation, one section was incubated in X-gal (5-bromo-4-chloro-3-indolyl-␤-dgalactosidase) staining solution (5 mm K 3 Fe(CN) 6 , 5 mm K 4 Fe(CN) 6 , 1 mg/ml X-gal and 1 mm MgCl 2 ) for 10 h at 37°C and the second section was stained with hematoxylin-eosin. Each specific hepatocellular lesion was diagnosed according to the classification of Squire and Levitt. 50 Lesions were classified as follows: (1) Neoplastic nodules: rounded lesions of several liver lobules in size in which normal liver architecture was lost. In these lesions portal areas are usually absent and there is a sharp demarcation from the rest of the liver parenchyma. Normal parenchyma is compressed by the expanding nodule. (2) HCC: these lesions are usually considerably larger and more irregular than neoplastic nodules and can involve major portions of liver lobes. At the periphery they compress or extend into the surrounding parenchyma and a fibrous capsule can be observed. In this study, different patterns of HCC were found: compact, trabecular and pseudoglandular. 51 Gene transfer was evaluated in a total of 20, 13, 33, 11, 10, 8, 8, 14, 10 and 25 neoplastic nodules in groups 1, 2, 4, 5, 6, 7, 8, 9, 10 and 11, respectively, and in addition 11, 6, 2, 8, 15, 5, 10, 8, 3, 5 and 4 HCC nodules in groups 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 and 11, respectively. The evaluation of X-gal-positive cells was carried out in six fields of the tumor nodule (three in the center of the nodule and three at the periphery) and in nontumoral tissue in each specimen. Gene transduction efficiency was expressed as a percentage of ␤-galactosidase expressing cells.
Immunohistochemical staining was performed using the peroxidase technique of Envision (Dako, Copenhagen, Denmark) with special antigen retrieval methods. Sections of formalin-fixed, paraffin-embedded tissues were deparaffinized and hydrated in a series of xylene, graded alcohol and water and finally washed in phosphate-buffered saline (PBS). Antigen unmasking was done either by incubating sections in 0.1% trypsin, pH 7.6, at 37°C for 15 min (for FN) or heating them in a microwave for 5 min in 10 mm citrate pH 6.0 (for LN and ␣-SMA). A monoclonal antibody to ␣-SMA (Dako), at a dilution of 1:100, a rabbit polyclonal antibody to FN (Sigma) at a dilution of 1:70, and a rabbit polyclonal antibody to LN (a gift of Dr Albrechtsen and Dr Wewer from the University of Copenhagen, Denmark) 34 at dilution of 1:1500 were used as primary antibodies. Antibody detection was done using the Envision Kit following the manufacturer's instruction (Dako). Slides were counterstained using Harris' hematoxylin. Negative control samples were performed by substituting the primary antibody with PBS. Staining was graded on semiquanti-tatively scale from − to ++ (− = no staining; + = mild staining; ++ = strong staining).
Statistics
Non-parametric Kruskal-Wallis and Mann-Whitney tests were used for statistical studies. All P values were two tailed and were considered statistically significant when the associated probability was less than 0.05. These analysis were made using the SPSS computer program for Windows (6.1.3 version).
